DNLI
Denali Therapeutics Inc.Company with tickers: DNLI
CIK
1714899
CUSIP
24823R105
Shares Outstanding
158,709,737
13F Activity (30d)
146 filings
145 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-03 | FLATLEY JAY T |
Director | Other | 336,313 |
| 2026-06-03 | Schenkein David P |
Director | Other | 31,232 |
| 2026-06-03 | Cook Jennifer E. |
Director | Award | 19,226 |
| 2026-06-03 | BAKER BROS. ADVISORS LP |
Director, 10% Owner | Award | 6,408 |
| 2026-06-03 | Klein Peter S |
Director | Award | 19,226 |
| 2026-06-03 | Schenkein David P |
Director | Award | 6,408 |
| 2026-06-03 | BAKER BROS. ADVISORS LP |
Director, 10% Owner | Award | 19,226 |
| 2026-06-03 | Thornberry Nancy |
Director | Award | 6,408 |
| 2026-06-03 | Cook Jennifer E. |
Director | Award | 6,408 |
| 2026-06-03 | Thornberry Nancy |
Director | Award | 19,226 |
| 2026-06-03 | Krognes Steve E. |
Director | Other | 781,797 |
| 2026-06-03 | FLATLEY JAY T |
Director | Award | 6,408 |
| 2026-06-03 | BAKER BROS. ADVISORS LP |
Director, 10% Owner | Award | 6,408 |
| 2026-06-03 | Schenkein David P |
Director | Other | 26,232 |
| 2026-06-03 | Van Hauwermeiren Timothy |
Director | Award | 6,408 |
| 2026-06-03 | Schenkein David P |
Director | Award | 19,226 |
| 2026-06-03 | Van Hauwermeiren Timothy |
Director | Award | 19,226 |
| 2026-06-03 | BAKER BROS. ADVISORS LP |
Director, 10% Owner | Award | 19,226 |
| 2026-06-03 | FLATLEY JAY T |
Director | Award | 19,226 |
| 2026-06-03 | Krognes Steve E. |
Director | Award | 6,408 |
| 2026-06-03 | Klein Peter S |
Director | Award | 6,408 |
| 2026-06-03 | Krognes Steve E. |
Director | Award | 19,226 |
| 2026-04-10 | Chin Peter Scott |
Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott |
Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott |
Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott |
Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott |
Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott |
Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott |
Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott |
Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott |
Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott |
Chief Medical Officer | Other | 170,612 |
| 2026-01-06 | Schuth Alexander O. |
COFO and Secretary | Other | 523,749 |
| 2026-01-06 | Watts Ryan J. |
Director, President and CEO | Other | 2,152,604 |
| 2026-01-06 | Watts Ryan J. |
Director, President and CEO | Sell | 35,198 |
| 2026-01-06 | Schuth Alexander O. |
COFO and Secretary | Sell | 17,218 |
| 2026-01-03 | Schuth Alexander O. |
COFO and Secretary | Award | 173,100 |
| 2026-01-03 | Watts Ryan J. |
Director, President and CEO | Other | 2,152,604 |
| 2026-01-03 | Schuth Alexander O. |
COFO and Secretary | Award | 57,700 |
| 2026-01-03 | Schuth Alexander O. |
COFO and Secretary | Other | 523,749 |
| 2026-01-03 | Watts Ryan J. |
Director, President and CEO | Award | 78,960 |
| 2026-01-03 | Watts Ryan J. |
Director, President and CEO | Award | 236,880 |
| 2025-12-11 | BAKER BROS. ADVISORS LP |
Director, 10% Owner | Buy | 190,523 |
| 2025-12-11 | BAKER BROS. ADVISORS LP |
Director, 10% Owner | Buy | 2,095,191 |
| 2025-11-04 | Van Hauwermeiren Timothy |
Director | Award | 31,897 |
| 2025-11-04 | Van Hauwermeiren Timothy |
Director | Other | 0 |
| 2025-11-04 | Van Hauwermeiren Timothy |
Director | Award | 10,632 |
| 2025-09-03 | Watts Ryan J. |
Director, President and CEO | Gift | 50,000 |
| 2025-09-03 | Watts Ryan J. |
Director, President and CEO | Other | 253,071 |
| 2025-08-13 | Ho Carole |
EVP & Pres, Lilly Neuroscience | Sell | 806 |
Showing 1–50 of 957 transactions